Global Chimeric Antigen Receptor T Cell Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size 2017-2028

2.1.2 Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Chimeric Antigen Receptor T Cell Therapy Segment by Type

2.2.1 Allogeneic

2.2.2 Autologous

2.3 Chimeric Antigen Receptor T Cell Therapy Market Size by Type

2.3.1 Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

2.4 Chimeric Antigen Receptor T Cell Therapy Segment by Application

2.4.1 Hospitals

2.4.2 Universities and Colleges

2.4.3 Others

2.5 Chimeric Antigen Receptor T Cell Therapy Market Size by Application

2.5.1 Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

3 Chimeric Antigen Receptor T Cell Therapy Market Size by Player

3.1 Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Players

3.1.1 Global Chimeric Antigen Receptor T Cell Therapy Revenue by Players (2020-2022)

3.1.2 Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Players (2020-2022)

3.2 Global Chimeric Antigen Receptor T Cell Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Chimeric Antigen Receptor T Cell Therapy by Regions

4.1 Chimeric Antigen Receptor T Cell Therapy Market Size by Regions (2017-2022)

4.2 Americas Chimeric Antigen Receptor T Cell Therapy Market Size Growth (2017-2022)

4.3 APAC Chimeric Antigen Receptor T Cell Therapy Market Size Growth (2017-2022)

4.4 Europe Chimeric Antigen Receptor T Cell Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022)

5.2 Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022)

5.3 Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2017-2022)

6.2 APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022)

6.3 APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Chimeric Antigen Receptor T Cell Therapy by Country (2017-2022)

7.2 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022)

7.3 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy by Region (2017-2022)

8.2 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.1 Global Chimeric Antigen Receptor T Cell Therapy Forecast by Regions (2023-2028)

10.1.1 Global Chimeric Antigen Receptor T Cell Therapy Forecast by Regions (2023-2028)

10.1.2 Americas Chimeric Antigen Receptor T Cell Therapy Forecast

10.1.3 APAC Chimeric Antigen Receptor T Cell Therapy Forecast

10.1.4 Europe Chimeric Antigen Receptor T Cell Therapy Forecast

10.1.5 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Forecast

10.2 Americas Chimeric Antigen Receptor T Cell Therapy Forecast by Country (2023-2028)

10.2.1 United States Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.2.2 Canada Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.2.3 Mexico Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.2.4 Brazil Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3 APAC Chimeric Antigen Receptor T Cell Therapy Forecast by Region (2023-2028)

10.3.1 China Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3.2 Japan Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3.3 Korea Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3.4 Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3.5 India Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.3.6 Australia Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.4 Europe Chimeric Antigen Receptor T Cell Therapy Forecast by Country (2023-2028)

10.4.1 Germany Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.4.2 France Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.4.3 UK Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.4.4 Italy Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.4.5 Russia Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.5 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Forecast by Region (2023-2028)

10.5.1 Egypt Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.5.2 South Africa Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.5.3 Israel Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.5.4 Turkey Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.5.5 GCC Countries Chimeric Antigen Receptor T Cell Therapy Market Forecast

10.6 Global Chimeric Antigen Receptor T Cell Therapy Forecast by Type (2023-2028)

10.7 Global Chimeric Antigen Receptor T Cell Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Amgen

11.1.1 Amgen Company Information

11.1.2 Amgen Chimeric Antigen Receptor T Cell Therapy Product Offered

11.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Amgen Main Business Overview

11.1.5 Amgen Latest Developments

11.2 Bellicum Pharmaceuticals

11.2.1 Bellicum Pharmaceuticals Company Information

11.2.2 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product Offered

11.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Bellicum Pharmaceuticals Main Business Overview

11.2.5 Bellicum Pharmaceuticals Latest Developments

11.3 Bluebird Bio

11.3.1 Bluebird Bio Company Information

11.3.2 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product Offered

11.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Bluebird Bio Main Business Overview

11.3.5 Bluebird Bio Latest Developments

11.4 Caribou Biosciences

11.4.1 Caribou Biosciences Company Information

11.4.2 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product Offered

11.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Caribou Biosciences Main Business Overview

11.4.5 Caribou Biosciences Latest Developments

11.5 Celgene Corporation

11.5.1 Celgene Corporation Company Information

11.5.2 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product Offered

11.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Celgene Corporation Main Business Overview

11.5.5 Celgene Corporation Latest Developments

11.6 Cellectis

11.6.1 Cellectis Company Information

11.6.2 Cellectis Chimeric Antigen Receptor T Cell Therapy Product Offered

11.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Cellectis Main Business Overview

11.6.5 Cellectis Latest Developments

11.7 Celyad Oncology

11.7.1 Celyad Oncology Company Information

11.7.2 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product Offered

11.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Celyad Oncology Main Business Overview

11.7.5 Celyad Oncology Latest Developments

11.8 Gilead Sciences

11.8.1 Gilead Sciences Company Information

11.8.2 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product Offered

11.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Gilead Sciences Main Business Overview

11.8.5 Gilead Sciences Latest Developments

11.9 Intellia Therapeutics

11.9.1 Intellia Therapeutics Company Information

11.9.2 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offered

11.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Intellia Therapeutics Main Business Overview

11.9.5 Intellia Therapeutics Latest Developments

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Information

11.10.2 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product Offered

11.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Johnson & Johnson Main Business Overview

11.10.5 Johnson & Johnson Latest Developments

11.11 Legend Biotech

11.11.1 Legend Biotech Company Information

11.11.2 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product Offered

11.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Legend Biotech Main Business Overview

11.11.5 Legend Biotech Latest Developments

11.12 Merck

11.12.1 Merck Company Information

11.12.2 Merck Chimeric Antigen Receptor T Cell Therapy Product Offered

11.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Merck Main Business Overview

11.12.5 Merck Latest Developments

11.13 Noile-Immune Biotech

11.13.1 Noile-Immune Biotech Company Information

11.13.2 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product Offered

11.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Noile-Immune Biotech Main Business Overview

11.13.5 Noile-Immune Biotech Latest Developments

11.14 Novartis

11.14.1 Novartis Company Information

11.14.2 Novartis Chimeric Antigen Receptor T Cell Therapy Product Offered

11.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Novartis Main Business Overview

11.14.5 Novartis Latest Developments

11.15 Pfizer

11.15.1 Pfizer Company Information

11.15.2 Pfizer Chimeric Antigen Receptor T Cell Therapy Product Offered

11.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Pfizer Main Business Overview

11.15.5 Pfizer Latest Developments

11.16 Sangamo Therapeutics

11.16.1 Sangamo Therapeutics Company Information

11.16.2 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offered

11.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Sangamo Therapeutics Main Business Overview

11.16.5 Sangamo Therapeutics Latest Developments

11.17 Servier Laboratories

11.17.1 Servier Laboratories Company Information

11.17.2 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product Offered

11.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Servier Laboratories Main Business Overview

11.17.5 Servier Laboratories Latest Developments

12 Research Findings and Conclusion

Table 1. Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Allogeneic

Table 3. Major Players of Autologous

Table 4. Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

Table 7. Chimeric Antigen Receptor T Cell Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

Table 10. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Player (2020-2022)

Table 12. Chimeric Antigen Receptor T Cell Therapy Key Players Head office and Products Offered

Table 13. Chimeric Antigen Receptor T Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Regions (2017-2022)

Table 18. Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Country (2017-2022)

Table 20. Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

Table 22. Americas Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

Table 24. APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Region (2017-2022)

Table 26. APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

Table 28. APAC Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

Table 30. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Country (2017-2022)

Table 32. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

Table 34. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor T Cell Therapy

Table 43. Key Market Challenges & Risks of Chimeric Antigen Receptor T Cell Therapy

Table 44. Key Industry Trends of Chimeric Antigen Receptor T Cell Therapy

Table 45. Global Chimeric Antigen Receptor T Cell Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Chimeric Antigen Receptor T Cell Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Chimeric Antigen Receptor T Cell Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 51. Amgen Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 52. Amgen Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 53. Amgen Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Amgen Main Business

Table 55. Amgen Latest Developments

Table 56. Bellicum Pharmaceuticals Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 57. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 58. Bellicum Pharmaceuticals Main Business

Table 59. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Bellicum Pharmaceuticals Latest Developments

Table 61. Bluebird Bio Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 62. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 63. Bluebird Bio Main Business

Table 64. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Bluebird Bio Latest Developments

Table 66. Caribou Biosciences Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 67. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 68. Caribou Biosciences Main Business

Table 69. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Caribou Biosciences Latest Developments

Table 71. Celgene Corporation Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 72. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 73. Celgene Corporation Main Business

Table 74. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Celgene Corporation Latest Developments

Table 76. Cellectis Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 77. Cellectis Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 78. Cellectis Main Business

Table 79. Cellectis Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Cellectis Latest Developments

Table 81. Celyad Oncology Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 82. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 83. Celyad Oncology Main Business

Table 84. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Celyad Oncology Latest Developments

Table 86. Gilead Sciences Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 87. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 88. Gilead Sciences Main Business

Table 89. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Gilead Sciences Latest Developments

Table 91. Intellia Therapeutics Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 92. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 93. Intellia Therapeutics Main Business

Table 94. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Intellia Therapeutics Latest Developments

Table 96. Johnson & Johnson Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 97. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 98. Johnson & Johnson Main Business

Table 99. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Johnson & Johnson Latest Developments

Table 101. Legend Biotech Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 102. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 103. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Legend Biotech Main Business

Table 105. Legend Biotech Latest Developments

Table 106. Merck Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 107. Merck Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 108. Merck Main Business

Table 109. Merck Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Merck Latest Developments

Table 111. Noile-Immune Biotech Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 112. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 113. Noile-Immune Biotech Main Business

Table 114. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Noile-Immune Biotech Latest Developments

Table 116. Novartis Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 117. Novartis Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 118. Novartis Main Business

Table 119. Novartis Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Novartis Latest Developments

Table 121. Pfizer Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 122. Pfizer Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 123. Pfizer Main Business

Table 124. Pfizer Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Pfizer Latest Developments

Table 126. Sangamo Therapeutics Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 127. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 128. Sangamo Therapeutics Main Business

Table 129. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Sangamo Therapeutics Latest Developments

Table 131. Servier Laboratories Details, Company Type, Chimeric Antigen Receptor T Cell Therapy Area Served and Its Competitors

Table 132. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product Offered

Table 133. Servier Laboratories Main Business

Table 134. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Servier Laboratories Latest Developments

List of Figures

Figure 1. Chimeric Antigen Receptor T Cell Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type in 2021

Figure 7. Chimeric Antigen Receptor T Cell Therapy in Hospitals

Figure 8. Global Chimeric Antigen Receptor T Cell Therapy Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Chimeric Antigen Receptor T Cell Therapy in Universities and Colleges

Figure 10. Global Chimeric Antigen Receptor T Cell Therapy Market: Universities and Colleges (2017-2022) & ($ Millions)

Figure 11. Chimeric Antigen Receptor T Cell Therapy in Others

Figure 12. Global Chimeric Antigen Receptor T Cell Therapy Market: Others (2017-2022) & ($ Millions)

Figure 13. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application in 2021

Figure 14. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Player in 2021

Figure 15. Global Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Chimeric Antigen Receptor T Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 17. APAC Chimeric Antigen Receptor T Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Europe Chimeric Antigen Receptor T Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Americas Chimeric Antigen Receptor T Cell Therapy Value Market Share by Country in 2021

Figure 21. Americas Chimeric Antigen Receptor T Cell Therapy Consumption Market Share by Type in 2021

Figure 22. Americas Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application in 2021

Figure 23. United States Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Region in 2021

Figure 28. APAC Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application in 2021

Figure 29. China Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Country in 2021

Figure 36. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type in 2021

Figure 37. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application in 2021

Figure 38. Germany Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Market Share by Application in 2021

Figure 46. Egypt Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Chimeric Antigen Receptor T Cell Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 52. APAC Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 53. Europe Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 55. United States Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Canada Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 59. China Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Japan Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Korea Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 63. India Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Australia Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Germany Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 66. France Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 67. UK Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Italy Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Russia Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Spain Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Israel Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Chimeric Antigen Receptor T Cell Therapy Market Size 2023-2028 ($ Millions)